Cargando…

Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B

PURPOSE: To study the changes in serum ferritin levels in lamivudine (LAM)-treated patients with chronic hepatitis and liver cirrhosis type B and determine whether successful treatment with LAM results in a reduction of serum ferritin levels. METHODS: Thirty patients with chronic hepatitis B virus (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohkoshi, Shogo, Yoshimura, Akira, Yamamoto, Satoshi, Yano, Masahiko, Kurita, So, Yamazaki, Kazuhide, Aoki, Yo-hei, Yamagiwa, Satoshi, Wakabayashi, Hiroto, Sugiyama, Motoya, Takahashi, Tohru, Ishikawa, Tohru, Matsuda, Yasunobu, Ichida, Takafumi, Kamimura, Tomoteru, Aoyagi, Yutaka
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716891/ https://www.ncbi.nlm.nih.gov/pubmed/19669269 http://dx.doi.org/10.1007/s12072-008-9084-z

Ejemplares similares

Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention
por: Ohkoshi, Shogo, et al.
Publicado: (2010)

Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis
por: Yamagiwa, Satoshi, et al.
Publicado: (2014)

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
por: Honda, Hiroki, et al.
Publicado: (2017)

DNA Damage Sensor γ-H2AX Is Increased in Preneoplastic Lesions of Hepatocellular Carcinoma
por: Matsuda, Yasunobu, et al.
Publicado: (2013)

A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
por: Osaki, Akihiko, et al.
Publicado: (2013)

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2012)

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Design of a gold clustering site in an engineered apo-ferritin cage
por: Lu, Chenlin, et al.
Publicado: (2022)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Diversion colitis and pouchitis: A mini-review
por: Tominaga, Kentaro, et al.
Publicado: (2018)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals
por: Akter, Shamima, et al.
Publicado: (2017)

Lamivudine-Induced Liver Injury
por: Olaniyan, Lamidi W. B., et al.
Publicado: (2015)

Lamivudine: fading into the mists of time
por: Choi, Jonggi, et al.
Publicado: (2017)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B
por: Shakado, Satoshi, et al.
Publicado: (2008)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
por: Chen, En-Qiang, et al.
Publicado: (2009)

Degree of methylation burden is determined by the exposure period to carcinogenic factors
por: Takeshima, Hideyuki, et al.
Publicado: (2017)

Different distribution of mucosal-associated invariant T cells within the human cecum and colon
por: Hama, Isamu, et al.
Publicado: (2019)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
por: Moon, Ju-Young, et al.
Publicado: (2012)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
por: Park, Chan Ho, et al.
Publicado: (2016)

Rare complication of hepatocellular carcinoma in Wilson's disease
por: Ohkoshi‐Yamada, Marina, et al.
Publicado: (2021)

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

Inhibitory effects of polysorbate 80 on MRSA biofilm formed on different substrates including dermal tissue
por: Ueda, Yutaka, et al.
Publicado: (2019)

Assessment of Growth Disturbance in Japanese Children with IBD
por: Shono, Tetsuo, et al.
Publicado: (2010)

Statistical Extraction Method for Revealing Key Factors from Posture before Initiating Successful Throwing Technique in Judo
por: Kato, Satoshi, et al.
Publicado: (2021)

Validity and Reliability of Japanese-Language Self-reported Measures for Assessing Adults Domain-Specific Sedentary Time
por: Ishii, Kaori, et al.
Publicado: (2018)

Lamivudine sensitivity - a case report
por: Budamakuntla, Leelavathy, et al.
Publicado: (2014)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
por: Luo, Aoran, et al.
Publicado: (2018)

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus
por: Kim, Kang Mo, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9590cdsc4ea2e7kpsahe4t1f6q